Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ALS trial design: expectation and reality.
Miller RG, Moore DH. Miller RG, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:52-4. doi: 10.1080/17434470410019979. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512873 No abstract available.
ALSFRS-R.
Gordon PH, Miller RG, Moore DH. Gordon PH, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:90-3. doi: 10.1080/17434470410019906. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512883 Review.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R; Western ALS Study Group. Gordon PH, et al. Lancet Neurol. 2007 Dec;6(12):1045-53. doi: 10.1016/S1474-4422(07)70270-3. Epub 2007 Nov 5. Lancet Neurol. 2007. PMID: 17980667 Clinical Trial.
Toward more efficient clinical trials for amyotrophic lateral sclerosis.
Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG. Cudkowicz ME, et al. Among authors: moore dh. Amyotroph Lateral Scler. 2010 May 3;11(3):259-65. doi: 10.3109/17482960903358865. Amyotroph Lateral Scler. 2010. PMID: 19961263 Review.
Phase I clinical trial of safety of L-serine for ALS patients.
Levine TD, Miller RG, Bradley WG, Moore DH, Saperstein DS, Flynn LE, Katz JS, Forshew DA, Metcalf JS, Banack SA, Cox PA. Levine TD, et al. Among authors: moore dh. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):107-111. doi: 10.1080/21678421.2016.1221971. Epub 2016 Sep 2. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 27589995 Free article. Clinical Trial.
7,114 results